AUDIO – Generics not done merging
Barr acquired Pliva. Teva gobbled up Ivax. Watson ate Andrx.
But the generic drug industry is not done consolidating, according to Barr Pharmaceuticals CEO Bruce Downey.
Aside from the top players in the industry, a second tier of generic drug companies could be the next acquisition targets, he told the Health Summit in a phone interview.